@misc{oai:repo.qst.go.jp:00063993,
 author = {Kamada, Tadashi and Imai, Reiko and Tsuji, Hiroshi and Imaizumi, Takeshi and Matsunobu, Akira and Okada, Tohru and Tsujii, Hirohiko and 鎌田 正 and 今井 礼子 and 辻 比呂志 and 今泉 猛 and 松延 亮 and 岡田 徹 and 辻井 博彦},
 month = {Sep},
 note = {The Heavy Ion Medical Accelerator in Chiba (HIMAC) is the world's first heavy ion accelerator complex dedicated to medical use in a hospital environment. Heavy ions have superior depth-dose distribution and greater cell-killing capability than other forms of radiation. In June 1996, clinical research for the treatment of bone and soft tissue sarcomas was begun using carbon ions generated by the HIMAC. As of February 2010, a total of 507 patients with bone and soft tissue sarcoma were enrolled in these clinical trials. Most of the patients had locally advanced and/or medically inoperable sarcomas. The clinical trials revealed that carbon ion radiotherapy provided definite local control and offered a survival advantage without unacceptable morbidity for patients with bone and soft tissue sarcomas that were hard to cure using other modalities., The 4th Japanese-European Joint Symposium on Ion Cancer Therapy and KI-NIRS Joint Symposium on Ion-Radiation Sciences},
 title = {Carbon Ion Radiotherapy in Bone and Soft Tissue Sarcomas},
 year = {2010}
}